Increased IL6 levels in peripheral blood and BM of NB patients reflect the characteristics of high-risk disease and poor prognosis (Egler et al., 2008; Ara et al., 2009; Ara et al., 2013). The gene discussed is IL6; the disease is neuroblastoma.